Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors

Cancer

Volumn 83, Issue 4, 1998, Pages 788-796

  Punnonen, Reijo ^a,b   Teisala, Klaus ^b   Kuoppala, Tapio ^b   Bennett, Bruce ^c   Punnonen, Juha ^c,d,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF TURKU   (Finland)

^e MAXYGEN INC   (United States)

Author keywords

Cytokine; Gynecologic cancer; Inflammation; T helper cell

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; CYTOKINE PRODUCTION; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HELPER CELL; HUMAN; IMMUNOREGULATION; INFLAMMATION; OVARY CARCINOMA; PERITONEAL FLUID; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ASCITIC FLUID; CYTOKINES; ENDOMETRIAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; MACROPHAGE COLONY-STIMULATING FACTOR; OVARIAN NEOPLASMS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 0031841126     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980815)83:4<788::AID-CNCR24>3.0.CO;2-N     Document Type: Article

References (36)

1. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-4.
2. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997;17:4015-23.
3. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989;57:503-12.
4. Irvine KR, Rao JB, Rosenberg SA, Restifo NP. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 1996; 156:238-45.
5. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
6. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9:532-62.
7. Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI, et al. Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Phys 1989;17:159-64.
8. Xu FJ, Ramakrishnan S, Daly L, Soper JT, Berchuck A, Clarke-Pearson D, et al. Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol 1991;165:1356-62.
9. Hakala A, Kacinski BM, Stanley ER, Kohorn EI, Puistola U, Risteli J, et al. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA125 and the aminoterminal propeptide of type III procollagen. Am J Obstet Gynecol 1995;173:112-9.
10. Price FV, Chambers SK, Chambers JT, Carcangiu ML, Schwartz PE, Kohorn EI, et al. Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am J Obstet Gynecol 1993;168:520-7.
11. Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 1993;72:2433-40.
12. Kawano Y, Takaue Y, Motoyoshi K, Minakuchi J, Kawashima S, Saito S, et al. Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. Exp Hematol 1993;21:220-3.
13. Yong K, Salooja N, Donahue RE, Hegde U, Linch DC. Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia. Blood 1992;80:2897-902.
14. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959-65.
15. Erroi A, Sironi M, Chiaffarino F, Chen ZG, Mengozzi M, Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989;44:795-801.
16. Haranaka K, Satomi N, Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984;34:263-7.
17. Punnonen J, Heinonen PK, Kuoppala T, Jansen CT, Punnonen R. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours. J Cancer Res Clin Oncol 1991;117: 587-92.
18. Yssel H, Johnson KE, Schneider PV, Wideman J, Terr A, Kastelein R, et al. T cell activation-inducing epitopes of the house dust mite allergen Der p 1. Proliferation and lymphokine production patterns by Der p 1-specific CD4+ T cell clones. J Immunol 1992;148:738-45.
19. Chretien I, Van Kimmenade A, Pearce M, Banchereau J, Abrams JS. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 1989;117:67-73.
20. + T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol 1990;144:902-8.
21. Wahlgren M, Abrams JS, Fernandez V, Bejarano MT, Azuma M, Torii M, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-I-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. Scand J Immunol 1995; 42:626-36.
22. Hagenbaugh A, Sharma S, Dubinett SM, Wei SH-Y, Aranda R, Cheroutre H, et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med 1997;185:2101-10.
23. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
24. Punnonen J, de Waal Malefyt R, van Vlasselar P, Gauchat J-F, De Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993;151:1280-9.
25. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 1991;67:990-6.
26. Groopman JE, Molina JM, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 1989;321:1449-59.
27. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
28. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
29. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses, J Immunol 1995;154:5492-9.
30. Gotlieb WH, Abrams JS, Watson JM, Velu TJ, Berek JS, Martinez-Maza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992;4:385-90.
31. Punnonen J, Teisala K, Ranta H, Bennett B, Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 1996;174:1522-6.
32. Qin Z, Noffz G, Mohaupt M, Blankenstein T. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage-colony-stimulating factor gene-modified tumor cells. J Immunol 1997;159: 770-6.
33. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1991;164:1038-42.
34. Scambia G, Testa U, Panici PB, Martucci R, Foti E, Petrini M, et al. Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer 1994;57:318-23.
35. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-51.
36. De Vries JE, Punnonen J. Interleukin-4 and interleukin-13. In: Snapper CM, editor. Cytokine regulation of humoral immunity: basic and clinical aspects. Chichester, United Kingdom: John Wiley & Sons, Ltd., 1996:195-215.